Table 1.
Correlations between IGF1 expression and clinical characteristics in patients with GC.
| Variables | Expression of IGF1 | p value | |
|---|---|---|---|
| High (n = 188) | Low (n = 187) | ||
| Age (years) | 0.25 | ||
| Age Mean (SD) | 65.2 (10.5) | 66.5 (10.8) | |
| Age Median [Min Max] | 66 [39 87] | 68 [35 90] | |
| Gender | 0.564 | ||
| Male | 124 (65.96%) | 117 (62.57%) | |
| Female | 64 (34.06%) | 70 (37.43%) | |
| Grade of differentiation | 0.001* | ||
| G1 | 3 (1.60%) | 7 (3.74%) | |
| G2 | 52 (27.66%) | 85 (45.45%) | |
| G3 | 128 (68.09%) | 91 (48.66%) | |
| GX | 5 (2.66%) | 4 (2.14%) | |
| Tumor invasion | 0.007* | ||
| T1 | 2 (0.53%) | 4 (2.14%) | |
| T2 | 36 (19.15%) | 44 (23.53%) | |
| T3 | 85 (45.21%) | 83 (44.39%) | |
| T4 | 58 (30.85%) | 42 (22.46%) | |
| TX | 7 (3.72%) | 1 (0.53%) | |
| Lymph node status | 0.293 | ||
| N0 | 47 (25.00%) | 64 (34.22%) | |
| N1 | 49 (26.06%) | 48 (25.67%) | |
| N2 | 39 (20.74%) | 36 (19.25%) | |
| N3 | 42 (22.34%) | 32 (17.11%) | |
| NX | 10 (5.32%) | 6 (3.21%) | |
| Distant metastasis | 0.52 | ||
| M0 | 162 (86.17%) | 168 (89.84%) | |
| M1 | 15 (7.98%) | 10 (5.35%) | |
| MX | 11 (5.85%) | 9 (4.81%) | |
| TNM stages | 0.012* | ||
| I | 15 (7.98%) | 38 (20.32%) | |
| II | 56 (29.79%) | 9 (29.41%) | |
| III | 82 (43.62%) | 68 (36.36%) | |
| IV | 18 (9.57%) | 20 (10.70%) | |
*Statistically significant. P value < 0.05 are in bold.